AnalystRadar
XENE Updated Aug 13, 2026

Xenon Pharmaceuticals Inc. (XENE)

Analyst consensus, price target and coverage. 19 analysts, updated daily.

Consensus Strong Buy= Unchanged
Price 65.26 USD
Mean target 81.30 USD
Upside +24.6% target vs price
Market cap Mid 6.3B

Analyst votes

How the ratings break down

20 ratings on record

Price targets

Where the estimates sit

How far apart analysts are on this name.

Low 69.00 Mean 81.30 High 100.00

share price 65.26 mean target 81.30. Analysts are spread 45% apart, and the share price sits below every target on record.

Most recent action

Last rating change

FirmRBC Capital
Date2026-08-07
ChangeOutperform → Outperform

Size and liquidity

Key statistics

Market cap6.31B USD
Cap classMid
Average volume1,352,409
Dollar volume per day88.3M
LiquidityHigh
Internal score82.7 / 100

Recommendation

How it moved, scan by scan

2 scans on record

ScanMoveConsensusScoreSBBuyHoldUndSell
2026-08-13 = Strong Buy 1.85 3 17 0 0 0
2026-08-11 · Strong Buy 1.85 3 17 0 0 0

Score is the analyst average on Yahoo's scale, where 1 is Strong Buy and 5 is Sell, so a falling number means the view improved. more positive, more negative, = unchanged.

History

Price target over time

2 daily points recorded

DatePriceTargetUpsideConsensus
2026-08-13 65.26 81.30 +24.6% Strong Buy
2026-08-11 64.09 81.30 +26.9% Strong Buy

Similar coverage

Comparable mid-cap names

Closest upside among companies of the same size.

← All 1035 companies in the screener